Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Benjaminf Mcgraw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
DURHAM - Aerie Pharmaceuticals has a new chief executive officer, naming veteran life science executive Raj Kannan to the post almost three months to the day
An accomplished leader Brings a depth and breadth of commercial, business development, and portfolio strategy experience ... | December 16, 2021
DURHAM - A licensing deal for two eye disease treatments means an $88 million upfront payment for Aerie Pharmaceuticals. Another $75 million will follow if
AERI earnings call for the period ending September 30, 2021.